BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34292492)

  • 1. Effectiveness and acceptability of a multidisciplinary approach in improving the care of patients with advanced chronic kidney disease: a pilot study.
    Kwek JL; Griva K; Kaur N; Chong KY; Chua ZY; Sim GHA; Ng LC; Yong PW; Tung YT; Lim LWW; Teo SH; Choo JCJ; Foo MWY; Jafar TH
    Int Urol Nephrol; 2022 Apr; 54(4):917-926. PubMed ID: 34292492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of multidisciplinary care for chronic kidney disease in Taiwan: a 3-year prospective cohort study.
    Chen YR; Yang Y; Wang SC; Chiu PF; Chou WY; Lin CY; Chang JM; Chen TW; Ferng SH; Lin CL
    Nephrol Dial Transplant; 2013 Mar; 28(3):671-82. PubMed ID: 23223224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of exercise training on estimated GFR, vascular health, and cardiorespiratory fitness in patients with CKD: a pilot randomized controlled trial.
    Greenwood SA; Koufaki P; Mercer TH; MacLaughlin HL; Rush R; Lindup H; O'Connor E; Jones C; Hendry BM; Macdougall IC; Cairns HS
    Am J Kidney Dis; 2015 Mar; 65(3):425-34. PubMed ID: 25236582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT.
    Malhotra R; Craven T; Ambrosius WT; Killeen AA; Haley WE; Cheung AK; Chonchol M; Sarnak M; Parikh CR; Shlipak MG; Ix JH;
    Am J Kidney Dis; 2019 Jan; 73(1):21-30. PubMed ID: 30291012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study.
    Chang AR; Evans M; Yule C; Bohn L; Young A; Lewis M; Graboski E; Gerdy B; Ehmann W; Brady J; Lawrence L; Antunes N; Green J; Snyder S; Kirchner HL; Grams M; Perkins R
    BMC Nephrol; 2016 Nov; 17(1):168. PubMed ID: 27825313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations Between Weight Loss, Kidney Function Decline, and Risk of ESRD in the Chronic Kidney Disease in Children (CKiD) Cohort Study.
    Ku E; Kopple JD; McCulloch CE; Warady BA; Furth SL; Mak RH; Grimes BA; Mitsnefes M
    Am J Kidney Dis; 2018 May; 71(5):648-656. PubMed ID: 29132947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceived Health and Quality of Life in Patients With CKD, Including Those With Kidney Failure: Findings From National Surveys in France.
    Legrand K; Speyer E; Stengel B; Frimat L; Ngueyon Sime W; Massy ZA; Fouque D; Laville M; Combe C; Jacquelinet C; Durand AC; Edet S; Gentile S; Briançon S; Ayav C
    Am J Kidney Dis; 2020 Jun; 75(6):868-878. PubMed ID: 31879215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Vitamin B
    Li Y; Spence JD; Wang X; Huo Y; Xu X; Qin X
    Am J Kidney Dis; 2020 Mar; 75(3):325-332. PubMed ID: 31629573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Virtual Multidisciplinary Care Program for Management of Advanced Chronic Kidney Disease: Matched Cohort Study.
    Kaiser P; Pipitone O; Franklin A; Jackson DR; Moore EA; Dubuque CR; Peralta CA; De Mory AC
    J Med Internet Res; 2020 Feb; 22(2):e17194. PubMed ID: 32049061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial.
    Sircar D; Chatterjee S; Waikhom R; Golay V; Raychaudhury A; Chatterjee S; Pandey R
    Am J Kidney Dis; 2015 Dec; 66(6):945-50. PubMed ID: 26233732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD.
    Crews DC; Scialla JJ; Boulware LE; Navaneethan SD; Nally JV; Liu X; Arrigain S; Schold JD; Ephraim PL; Jolly SE; Sozio SM; Michels WM; Miskulin DC; Tangri N; Shafi T; Wu AW; Bandeen-Roche K;
    Am J Kidney Dis; 2014 May; 63(5):806-15. PubMed ID: 24508475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Yang W; Xie D; Anderson AH; Joffe MM; Greene T; Teal V; Hsu CY; Fink JC; He J; Lash JP; Ojo A; Rahman M; Nessel L; Kusek JW; Feldman HI;
    Am J Kidney Dis; 2014 Feb; 63(2):236-43. PubMed ID: 24182662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study.
    Miskulin DC; Abebe KZ; Chapman AB; Perrone RD; Steinman TI; Torres VE; Bae KT; Braun W; Winklhofer FT; Hogan MC; Rahbari-Oskoui F; Moore CG; Flessner MF; Schrier RW;
    Am J Kidney Dis; 2014 Feb; 63(2):214-26. PubMed ID: 24183837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting.
    Kaboré NF; Poda A; Zoungrana J; Da O; Ciaffi L; Semdé A; Yaméogo I; Sawadogo AB; Delaporte E; Meda N; Limou S; Cournil A
    BMC Nephrol; 2019 May; 20(1):155. PubMed ID: 31064340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Kidney Function Outcomes Following RAAS Inhibition in Patients With Heart Failure With Reduced Ejection Fraction.
    McCallum W; Tighiouart H; Ku E; Salem D; Sarnak MJ
    Am J Kidney Dis; 2020 Jan; 75(1):21-29. PubMed ID: 31303349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility and acceptability of telehealth coaching to promote healthy eating in chronic kidney disease: a mixed-methods process evaluation.
    Kelly JT; Warner MM; Conley M; Reidlinger DP; Hoffmann T; Craig J; Tong A; Reeves M; Johnson DW; Palmer S; Campbell KL
    BMJ Open; 2019 Jan; 9(1):e024551. PubMed ID: 30700482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GFR decline and subsequent risk of established kidney outcomes: a meta-analysis of 37 randomized controlled trials.
    Lambers Heerspink HJ; Tighiouart H; Sang Y; Ballew S; Mondal H; Matsushita K; Coresh J; Levey AS; Inker LA
    Am J Kidney Dis; 2014 Dec; 64(6):860-6. PubMed ID: 25441439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimated GFR Trajectories of People Entering CKD Stage 4 and Subsequent Kidney Disease Outcomes and Mortality.
    Xie Y; Bowe B; Xian H; Balasubramanian S; Al-Aly Z
    Am J Kidney Dis; 2016 Aug; 68(2):219-228. PubMed ID: 26948835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies.
    Minutolo R; Gabbai FB; Chiodini P; Provenzano M; Borrelli S; Garofalo C; Bellizzi V; Russo D; Conte G; De Nicola L;
    Am J Kidney Dis; 2020 Jan; 75(1):30-38. PubMed ID: 31409508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.